Lucid Diagnostics Inc. Quarterly Return On Equity in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Lucid Diagnostics Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q3 2024.
  • Lucid Diagnostics Inc. Return On Equity for the quarter ending September 30, 2024 was -562 %, a 62.3% decline year-over-year.
  • Lucid Diagnostics Inc. annual Return On Equity for 2023 was -524 %, a 211% decline from 2022.
  • Lucid Diagnostics Inc. annual Return On Equity for 2022 was -169 %, a 109% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -562 -216 -62.3% Jul 1, 2024 Sep 30, 2024
Q2 2024 -664 -412 -164% Apr 1, 2024 Jun 30, 2024
Q1 2024 -691 -476 -221% Jan 1, 2024 Mar 31, 2024
Q4 2023 -524 -355 -211% Oct 1, 2023 Dec 31, 2023
Q3 2023 -346 -219 -172% Jul 1, 2023 Sep 30, 2023
Q2 2023 -251 -92 -57.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -215 +41.5 +16.2% Jan 1, 2023 Mar 31, 2023
Q4 2022 -169 -2.14K -109% Oct 1, 2022 Dec 31, 2022
Q3 2022 -127 Jul 1, 2022 Sep 30, 2022
Q2 2022 -159 Apr 1, 2022 Jun 30, 2022
Q1 2022 -257 Jan 1, 2022 Mar 31, 2022
Q4 2021 1.97K Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.